Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (57) 57
hygiene (57) 57
medical or veterinary science (57) 57
devices for introducing media into, or onto, the body (48) 48
devices for producing or ending sleep or stupor (48) 48
devices for transducing body media or for taking media fromthe body (48) 48
humans (18) 18
respiratory system (15) 15
performing operations (14) 14
transporting (14) 14
administration, inhalation (13) 13
particle size (13) 13
female (12) 12
inhalation (12) 12
lung - metabolism (12) 12
adult (11) 11
lung deposition (11) 11
male (11) 11
devices, apparatus or methods for life-saving (10) 10
fire-fighting (10) 10
life-saving (10) 10
diagnosis (9) 9
general tagging of cross-sectional technologies spanning over several sections of the ipc (9) 9
general tagging of new technological developments (9) 9
identification (9) 9
middle aged (9) 9
surgery (9) 9
technical subjects covered by former us classification (9) 9
technical subjects covered by former uspc (9) 9
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (9) 9
blasting (8) 8
chemical or physical processes, e.g. catalysis or colloidchemistry (8) 8
drying (8) 8
drying solid materials or objects by removing liquid therefrom (8) 8
heating (8) 8
lighting (8) 8
mechanical engineering (8) 8
physical or chemical processes or apparatus in general (8) 8
preparations for medical, dental, or toilet purposes (8) 8
their relevant apparatus (8) 8
tissue distribution (8) 8
weapons (8) 8
aerosols (7) 7
aged (7) 7
nebulizers and vaporizers (7) 7
magnetic or electrostatic separation of solid materials from solidmaterials or fluids (6) 6
magnetic or electrostatic separation of solid materials fromsolid materials or fluids (6) 6
separation by high-voltage electric fields (6) 6
separation of solid materials using liquids or using pneumatictables or jigs (6) 6
asthma (5) 5
chronic obstructive pulmonary disease (5) 5
cross-over studies (5) 5
deposition (5) 5
drug delivery systems (5) 5
formoterol (5) 5
formoterol fumarate (5) 5
health technology assessment (5) 5
original research (5) 5
scintigraphy (5) 5
bronchodilator agents - administration & dosage (4) 4
clearance (4) 4
ethanolamines - administration & dosage (4) 4
lung - diagnostic imaging (4) 4
lungs (4) 4
respiration (4) 4
abstracts (3) 3
bronchodilator agents - pharmacokinetics (3) 3
case-control studies (3) 3
cystic fibrosis (3) 3
drug delivery systems - instrumentation (3) 3
drug dosages (3) 3
drug therapy (3) 3
forced expiratory volume (3) 3
forced expiratory volume - physiology (3) 3
index medicus (3) 3
inhaled drug (3) 3
lung (3) 3
lung - physiopathology (3) 3
lung diseases (3) 3
lung imaging (3) 3
metered dose inhalers (3) 3
metered-dose inhaler (3) 3
original papers (3) 3
public, environmental & occupational health (3) 3
pulmonary disease, chronic obstructive - drug therapy (3) 3
pulmonary disease, chronic obstructive - metabolism (3) 3
radionuclide imaging - methods (3) 3
radiopharmaceuticals - administration & dosage (3) 3
therapy (3) 3
young adult (3) 3
adolescent (2) 2
aerosol (2) 2
alpha-1-antitrypsin (2) 2
andersen cascade impactor (2) 2
anti-inflammatory agents - administration & dosage (2) 2
anti-inflammatory agents - pharmacokinetics (2) 2
articles (2) 2
asthma - metabolism (2) 2
asthma - physiopathology (2) 2
cardiac & cardiovascular systems (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Deposition, Retention, and Translocation of Ultrafine Particles from the Central Airways and Lung Periphery
by Moller, Winfried and Felten, Kathrin and Sommerer, Knut and Scheuch, Gerhard and Meyer, Gabriele and Meyer, Peter and Haussinger, Karl and Kreyling, Wolfgang G
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 02/2008, Volume 177, Issue 4, pp. 426 - 432
Rationale: Little is known about clearance of ultrafine carbon particles from the different regions of the human lung. These particles may accumulate and... 
Translocation | Air pollution | Ultrafine particles | Clearance | translocation | CIRCULATION | INHALATION | SIZE | HEALTHY | LONG-TERM CLEARANCE | REGIONAL DEPOSITION | NANOPARTICLES | RESPIRATORY SYSTEM | ultrafine particles | clearance | air pollution | MUCUS | CRITICAL CARE MEDICINE | Air Pollutants - analysis | Humans | Middle Aged | Air Pollutants - pharmacokinetics | Male | Reference Values | Case-Control Studies | Tissue Distribution | Biological Transport | Female | Lung - metabolism | Pulmonary Disease, Chronic Obstructive - metabolism | Radiopharmaceuticals | Aerosols - pharmacology | Carbon - urine | Mucociliary Clearance | Administration, Inhalation | Probability | Carbon - administration & dosage | Carbon - pharmacokinetics | Particle Size | Smoking - metabolism | Aged | Respiratory Function Tests | Respiratory Mechanics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Ciprofloxacin Dry Powder for Inhalation: Inspiratory Flow in Patients with Non-cystic Fibrosis Bronchiectasis
by Stass, H and Nagelschmitz, J and Kappeler, D and Sommerer, K and Patzlaff, A and Weimann, B
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, ISSN 1941-2711, 06/2019, Volume 32, Issue 3, pp. 156 - 163
Background: As non-cystic fibrosis bronchiectasis (NCFB) progresses, patients suffer irreversible lung damage and deterioration in lung function. This study... 
inhaled antibiotics | dry powder for inhalation | RESPIRATORY SYSTEM | peak inspiratory flow | non-CF bronchiectasis | Respiratory therapy | Drug delivery systems | Respiratory function | Cystic fibrosis | Flow rates | Drug delivery | Bronchiectasis | Powder | Inhalation | Air flow | Lungs | Fibrosis | Flow velocity | Respiration | Ciprofloxacin
Journal Article
Details down arrow
3. Ciprofloxacin Dry Powder for Inhalation in Patients with Non-Cystic Fibrosis Bronchiectasis or Chronic Obstructive Pulmonary Disease, and in Healthy Volunteers
by Stass, Heino and Nagelschmitz, Johannes and Kappeler, Dominik and Sommerer, Knut and Kietzig, Claudius and Weimann, Boris
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 02/2017, Volume 30, Issue 1, pp. 53 - 63
Background: Ciprofloxacin dry powder for inhalation (Ciprofloxacin DPI) is in development as long-term intermittent therapy to reduce the frequency of acute... 
charcoal block | lung deposition | NCFB | scintigraphy | non-cystic fibrosis bronchiectasis | Ciprofloxacin DPI (dry powder for inhalation) | chronic obstructive pulmonary disease | COPD | LONG-TERM | DOSE-ESCALATION | TOBRAMYCIN | PHARMACOKINETICS | RESPIRATORY SYSTEM | PHASE-I | Dry Powder Inhalers | Bronchiectasis - drug therapy | Humans | Middle Aged | Administration, Inhalation | Biological Availability | Male | Lung - physiopathology | Ciprofloxacin - pharmacokinetics | Case-Control Studies | Cross-Over Studies | Tissue Distribution | Young Adult | Ciprofloxacin - administration & dosage | Anti-Bacterial Agents - pharmacokinetics | Adult | Female | Aged | Lung - metabolism | Anti-Bacterial Agents - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy
Journal Article
Details down arrow
4. Full Text Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients
by De Backer, Wilfried and Devolder, Annick and Poli, Gianluigi and Acerbi, Daniela and Monno, Raffaella and Herpich, Christiane and Sommerer, Knut and Meyer, Thomas and Mariotti, Fabrizia
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 06/2010, Volume 23, Issue 3, pp. 137 - 148
Background: When inhaling medication, it is essential that drug particles are delivered to all sites of lung inflammation, including the peripheral airways.... 
Hydrofluoroalkane | Lung deposition | Beclomethasone dipropionate | Small airways | Formoterol | Chronic obstructive pulmonary disease | Extra fine | Asthma | MODERATE | SALBUTAMOL | hydrofluoroalkane | lung deposition | COMBINATION THERAPY | FIXED COMBINATION | INHALATION | asthma | formoterol | METERED-DOSE INHALER | RESPIRATORY SYSTEM | INFLAMMATION | beclomethasone dipropionate | PARTICLE-SIZE | small airways | chronic obstructive pulmonary disease | extra fine | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Beclomethasone - pharmacokinetics | Humans | Middle Aged | Male | Ethanolamines - administration & dosage | Case-Control Studies | Forced Expiratory Volume | Tissue Distribution | Ethanolamines - pharmacokinetics | Metered Dose Inhalers | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Lung - metabolism | Beclomethasone - administration & dosage | Administration, Inhalation | Asthma - drug therapy | Particle Size | Bronchodilator Agents - pharmacokinetics | Aged | Respiratory Function Tests | Drug Combinations | Pulmonary Disease, Chronic Obstructive - drug therapy | Lung diseases, Obstructive | Usage | Corticosteroids | Research | Drug therapy | Health aspects | Risk factors | Original Research
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler
by Kappeler, Dominik and Sommerer, Knut and Kietzig, Claudius and Huber, Bärbel and Woodward, Jo and Lomax, Mark and Dalvi, Prashant
Respiratory Medicine, ISSN 0954-6111, 05/2018, Volume 138, pp. 107 - 114
A combination of fluticasone propionate/formoterol fumarate (FP/FORM) has been incorporated within a novel, breath-triggered device, named K-haler . This low... 
Formoterol fumarate | Radiolabelled | Scintigraphy | Deposition | Fluticasone propionate | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | SAFETY | COMBINATION THERAPY | PLUME CHARACTERISTICS | FLOW | TRIAL | METERED-DOSE INHALER | LUNG DEPOSITION | HYDROFLUOROALKANE-134A BECLOMETHASONE | RESPIRATORY SYSTEM | EXACERBATIONS | Asthma - metabolism | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Healthy Volunteers | Equipment Design | Young Adult | Inhalation - physiology | Fluticasone - pharmacokinetics | Sodium Pertechnetate Tc 99m | Metered Dose Inhalers | Adult | Female | Lung - metabolism | Pulmonary Disease, Chronic Obstructive - metabolism | Asthma - physiopathology | Forced Expiratory Volume - physiology | Administration, Inhalation | Particle Size | Diagnostic Imaging | Fluticasone - administration & dosage | Bronchodilator Agents - pharmacokinetics | Vital Capacity - physiology | Adolescent | Formoterol Fumarate - pharmacokinetics | Radionuclide Imaging - methods | Aged | Drug Combinations | Nebulizers and Vaporizers | Formoterol Fumarate - administration & dosage | Formoterol | Analysis | Asthmatics | Asthma | Steroids | Drug delivery systems | Image processing | Life assessment | Fluticasone | Mental depression | Low resistance | Dosage | Population | Chronic obstructive pulmonary disease | Drug dosages | Ethanol | Propionic acid | Lung diseases | Regional analysis | Flow rates | Patients | Inhalation | Image analysis | Obstructive lung disease | Flow velocity | Image transmission | Respiration
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Lung Deposition of the Dry Powder Fixed Combination Beclometasone Dipropionate Plus Formoterol Fumarate Using NEXThaler ® Device in Healthy Subjects, Asthmatic Patients, and COPD Patients
by Virchow, Johann Christian and Poli, Gianluigi and Herpich, Christiane and Kietzig, Claudius and Ehlich, Hilke and Braeutigam, Daniela and Sommerer, Knut and Häussermann, Sabine and Mariotti, Fabrizia
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 10/2018, Volume 31, Issue 5, pp. 269 - 280
This study evaluated the lung deposition and the distribution pattern in the airways of a fixed combination of beclometasone dipropionate (BDP) and formoterol... 
NEXThaler | inhaled drug | lung deposition | asthma | DPI | BDP/formoterol combination | COPD | NEXThaler((R)) DPI | HFA-BECLOMETHASONE | VOLUNTEERS | SMALL AIRWAYS | formoterol combination | BDP | METERED-DOSE INHALER | THERAPY | RESPIRATORY SYSTEM | OBSTRUCTION | PARTICLE-SIZE | Respiratory therapy | Particle size | Respiratory function | Chlorofluorocarbons | Lung diseases | Pharmacology | Scintigraphy | Dosage | Patients | Powder | Inhalation | Asthma | Airway management | Lungs | Formoterol | Chronic obstructive pulmonary disease | Respiration | Drug dosages | Deposition
Journal Article
Details down arrow
7. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis
by Häussermann, Sabine and Winnips, Cornelis and Edelman, Jonathan and Kappeler, Dominik and Herpich, Christiane and Ehlich, Hilke and Zanker, Daniela and Kietzig, Claudius and Sommerer, Knut
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 06/2016, Volume 29, Issue 3, pp. 242 - 250
In cystic fibrosis (CF) patients, inhalation of alpha1-proteinase inhibitor (A1-PI) can prevent or slow down persistent infections and reduce the massive... 
lung imaging | inhaled drug | lung deposition | cystic fibrosis | scintigraphy | I-neb AAD System | nebulizer | alpha1-proteinase inhibitor | alpha-1-antitrypsin | pulmonary function testing | Drug Delivery Systems - instrumentation | Cystic Fibrosis - physiopathology | Humans | Male | Equipment Design | Tissue Distribution | Young Adult | Anti-Inflammatory Agents - adverse effects | Adult | Anti-Inflammatory Agents - administration & dosage | Anti-Inflammatory Agents - pharmacokinetics | Female | Lung - metabolism | Anti-Infective Agents - adverse effects | Cystic Fibrosis - metabolism | Administration, Inhalation | Lung - physiopathology | Inhalation | Cross-Over Studies | alpha 1-Antitrypsin - administration & dosage | Algorithms | Anti-Infective Agents - administration & dosage | Models, Biological | Anti-Infective Agents - pharmacokinetics | Lung - drug effects | Aerosols | alpha 1-Antitrypsin - pharmacokinetics | Cystic Fibrosis - drug therapy | Germany | Nebulizers and Vaporizers | alpha 1-Antitrypsin - adverse effects
Journal Article
Details down arrow
8. Full Text Standardization of Techniques for Using Planar (2D) Imaging for Aerosol Deposition Assessment of Orally Inhaled Products
by Newman, Stephen and Bennett, William D and Biddiscombe, Martyn and Devadason, Sunalene G and Dolovich, Myrna B and Fleming, John and Haeussermann, Sabine and Kietzig, Claudius and Kuehl, Philip J and Laube, Beth L and Sommerer, Knut and Taylor, Glyn and Usmani, Omar S and Zeman, Kirby L
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 12/2012, Volume 25, Issue S1, pp. S-1 - S-28
Two-dimensional (2D or planar) imaging with 99m Tc radiolabels enables quantification of whole-lung and regional lung depositions for orally inhaled drug... 
Articles | orally inhaled products | gamma scintigraphy | lung deposition | planar imaging | COUGH CLEARANCE | PARTICLES | QUANTIFICATION | REGIONAL DEPOSITION | MUCOCILIARY CLEARANCE | DRY POWDER INHALER | RESPIRATORY SYSTEM | GAMMA-SCINTIGRAPHY | BREATHING PATTERN | CYSTIC-FIBROSIS | Radiopharmaceuticals - chemistry | Radiopharmaceuticals - pharmacokinetics | Humans | Administration, Inhalation | Lung - diagnostic imaging | Drug Delivery Systems | Radiopharmaceuticals - administration & dosage | Tissue Distribution | Pharmaceutical Preparations - metabolism | Radionuclide Imaging - instrumentation | Radionuclide Imaging - standards | Pharmaceutical Preparations - chemistry | Radionuclide Imaging - methods | Aerosols | Pharmaceutical Preparations - administration & dosage | Technetium - chemistry
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma
by Sommerer, Florian and Vieth, Michael and Markwarth, Annett and Röhrich, Knut and Vomschloß, Susanne and May, Andrea and Ell, Christian and Stolte, Manfred and Hengge, Ulrich R and Wittekind, Christian and Tannapfel, Andrea
Oncogene, ISSN 0950-9232, 01/2004, Volume 23, Issue 2, pp. 554 - 558
Activation of the Raf/MEK/ERK (MAPK) signal transduction cascade by RAS mutations has been found in a variety of human cancers. Mutations of BRAF provide an... 
BRAF | Barrett | Neoplasia | KRAS2 | barrett | ACTIVATION | ESOPHAGUS | BIOCHEMISTRY & MOLECULAR BIOLOGY | CANCER | neoplasia | CELL BIOLOGY | MELANOMA | GENE | ONCOLOGY | PATHWAY | GENETICS & HEREDITY | B-RAF | PROTEINS | CARCINOMA | PROGRESSION | Immunohistochemistry | Proto-Oncogene Proteins p21(ras) | ras Proteins | Proto-Oncogene Proteins c-raf - genetics | Humans | Adenocarcinoma - enzymology | Proto-Oncogene Proteins - genetics | Mutation - genetics | DNA Mutational Analysis | Base Sequence | Barrett Esophagus - enzymology | Adenocarcinoma - genetics | Proto-Oncogene Proteins B-raf | Barrett Esophagus - genetics | Genes, ras - genetics | Mitogen-Activated Protein Kinases - metabolism | BRAF gene | Raf protein | mismatch repair | KRAS2 gene | MEK protein | Barrett's adenocarcinoma
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Validation of Radiolabeling of Drug Formulations for Aerosol Deposition Assessment of Orally Inhaled Products
by Devadason, Sunalene G and Chan, Hak-Kim and Haeussermann, Sabine and Kietzig, Claudius and Kuehl, Philip J and Newman, Stephen and Sommerer, Knut and Taylor, Glyn
Journal of Aerosol Medicine and Pulmonary Drug Delivery, ISSN 1941-2711, 12/2012, Volume 25, Issue S1, pp. S-6 - S-9
Radiolabeling of inhaler formulations for imaging studies is an indirect method of determining lung deposition and regional distribution of drug in human... 
Articles | aerosol deposition studies | radiolabeling methods | WORKSHOP | MEDICATIONS | MDIS | RESPIRATORY SYSTEM | INHALATION | DELIVERY | Radiopharmaceuticals - chemistry | Radiopharmaceuticals - pharmacokinetics | Humans | Administration, Inhalation | Lung - diagnostic imaging | Drug Delivery Systems | Particle Size | Radiopharmaceuticals - administration & dosage | Tissue Distribution | Pharmaceutical Preparations - metabolism | Pharmaceutical Preparations - chemistry | Radionuclide Imaging - methods | Aerosols | Lung - metabolism | Pharmaceutical Preparations - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Insulin Lung Deposition and Clearance Following Technosphere® Insulin Inhalation Powder Administration
by Cassidy, James P and Amin, Nikhil and Marino, Mark and Gotfried, Mark and Meyer, Thomas and Sommerer, Knut and Baughman, Robert A
Pharmaceutical Research, ISSN 0724-8741, 9/2011, Volume 28, Issue 9, pp. 2157 - 2164
To determine distribution and deposition of Technosphere® Insulin (TI) inhalation powder and the rate of clearance of fumaryl diketopiperazine (FDKP; major... 
Biomedical Engineering | Biochemistry, general | Afrezza | fumaryl diketopiperazine | Biomedicine | Technosphere Insulin inhalation powder | insulin clearance | Pharmacy | inhalation powder | Medical Law | Pharmacology/Toxicology | insulin lung disposition | Insulin lung disposition | Insulin clearance | Fumaryl diketopiperazine | Inhalation powder | Technosphere insulin inhalation powder | INHALED INSULIN | PHARMACOLOGY & PHARMACY | Afrezza (R) | ABSORPTION | CHEMISTRY, MULTIDISCIPLINARY | Sodium Pertechnetate Tc 99m - chemistry | Drug Delivery Systems - instrumentation | Humans | Male | Metabolic Clearance Rate | Lung - diagnostic imaging | Drug Carriers - chemistry | Tissue Distribution | Hypoglycemic Agents - administration & dosage | Adult | Female | Lung - metabolism | Piperazines - pharmacokinetics | Hypoglycemic Agents - pharmacokinetics | Powders | Administration, Inhalation | Insulin - administration & dosage | Hypoglycemic Agents - chemistry | Particle Size | Fumarates - analysis | Piperazines - analysis | Fumarates - pharmacokinetics | Insulin - chemistry | Radionuclide Imaging | Drug Carriers - pharmacokinetics | Bronchoalveolar Lavage Fluid - chemistry | Drug Delivery Systems - methods | Insulin - pharmacokinetics | Nebulizers and Vaporizers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD
by Meyer, Thomas and Reitmeir, Peter and Brand, Peter and Herpich, Christiane and Sommerer, Knut and Schulze, Anja and Scheuch, Gerhard and Newman, Stephen
Respiratory Medicine, ISSN 0954-6111, 2011, Volume 105, Issue 6, pp. 900 - 906
Summary Background Lung mucociliary clearance is impaired in patients with chronic obstructive pulmonary disease (COPD). Treatment guidelines recommend that... 
Pulmonary/Respiratory | Formoterol | Mucus clearance | Tiotropium bromide | CHRONIC-BRONCHITIS | CARDIAC & CARDIOVASCULAR SYSTEMS | AEROSOLS | COUGH CLEARANCE | DEPOSITION | LUNG MUCOCILIARY CLEARANCE | OBSTRUCTIVE PULMONARY-DISEASE | THERAPY | RESPIRATORY SYSTEM | TERBUTALINE | AIRWAYS | IPRATROPIUM BROMIDE | Ethanolamines - pharmacology | Spirometry | Formoterol Fumarate | Bronchodilator Agents - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Mucus - drug effects | Ethanolamines - administration & dosage | Adult | Female | Quality of Life - psychology | Scopolamine Derivatives | Drug Therapy, Combination | Tiotropium Bromide | Dry Powder Inhalers | Forced Expiratory Volume - physiology | Administration, Inhalation | Bronchodilator Agents - pharmacology | Mucus - secretion | Pulmonary Disease, Chronic Obstructive - complications | Cross-Over Studies | Pulmonary Disease, Chronic Obstructive - psychology | Aged | Pulmonary Disease, Chronic Obstructive - drug therapy | Antiasthmatic agents | Lung diseases, Obstructive | Care and treatment | Parasympatholytic agents | Drug therapy | Retention | Drug dosages | Personal relationships | Manuscripts | Smoking
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Insulin Lung Deposition and Clearance Following Technosphere^sup ?^ Insulin Inhalation Powder Administration
by James P Cassidy and Nikhil Amin and Mark Marino and Mark Gotfried and Thomas Meyer and Knut Sommerer and Robert A Baughman
Pharmaceutical Research, ISSN 0724-8741, 09/2011, Volume 28, Issue 9, p. 2157
  To determine distribution and deposition of Technosphere^sup ®^ Insulin (TI) inhalation powder and the rate of clearance of fumaryl diketopiperazine (FDKP;... 
Drug delivery systems | Lungs | Insulin | Pharmaceutical sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Insulin Lung Deposition and Clearance Following Technosphere.sup. Insulin Inhalation Powder Administration
by Cassidy, James P and Amin, Nikhil and Marino, Mark and Gotfried, Mark and Meyer, Thomas and Sommerer, Knut and Baughman, Robert A
Pharmaceutical Research, ISSN 0724-8741, 09/2011, Volume 28, Issue 9, p. 2157
To determine distribution and deposition of Technosphere.sup.(r) Insulin (TI) inhalation powder and the rate of clearance of fumaryl diketopiperazine (FDKP... 
Powders | Insulin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text In vitro and in vivo dose delivery characteristics of large porous particles for inhalation
by Dunbar, Craig and Scheuch, Gerhard and Sommerer, Knut and DeLong, Mark and Verma, Alka and Batycky, Rick
International Journal of Pharmaceutics, ISSN 0378-5173, 2002, Volume 245, Issue 1, pp. 179 - 189
The purpose of this study was to evaluate the in vitro and in vivo dose delivery characteristics of two large porous particle placebo formulations with... 
Large porous particles | Lung deposition | Inhalation | large porous particles | PULMONARY DRUG-DELIVERY | inhalation | IN-VITRO | HUMAN RESPIRATORY-TRACT | AEROSOL | MODELS | lung deposition | DEPOSITION | PHARMACOLOGY & PHARMACY | INHALER | Double-Blind Method | Humans | Middle Aged | Administration, Inhalation | Spectrometry, Fluorescence | Technetium | Cross-Over Studies | Particle Size | Powders - chemistry | Tissue Distribution | Powders - pharmacokinetics | Models, Biological | Adult | Female | Lung - metabolism | Porosity | Nebulizers and Vaporizers
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text The Physical and Biological Doses of Methacholine Are Different for Mefar MB3 and Jaeger APS Sidestream Nebulizers
by Praml, Georg and Scharrer, Eva and de la Motte, Dorothea and Nowak, Dennis and Scheuch, Gerhard and Sommerer, Knut and Radon, Katja
Chest, ISSN 0012-3692, 11/2005, Volume 128, Issue 5, pp. 3585 - 3589
Within a study on respiratory symptoms in rural areas, we used the European Community Respiratory Health Survey methacholine challenge protocol. For quicker... 
ECRHS = European Community Respiratory Health Survey | residual method | MMAD = mass median aerodynamic diameter | Lower Saxony Lung Study | PD20= provocative dose of methacholine causing a 20% drop in FEV1 | bronchial hyperresponsiveness | methacholine | Bronchial hyperresponsiveness | Methacholine | Residual method | RESPONSIVENESS | RESPIRATORY SYSTEM | DOSIMETER | AEROSOL OUTPUT | CRITICAL CARE MEDICINE | Forced Expiratory Volume | Particle Size | Bronchoconstrictor Agents - administration & dosage | Methacholine Chloride - administration & dosage | Bronchial Hyperreactivity - drug therapy | Humans | Bronchial Provocation Tests | Adult | Female | Male | Nebulizers and Vaporizers | Pulmonary manifestations of general diseases | Complications and side effects | Lung diseases | Dosage and administration | Research | Drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Preparation of spherical monodisperse ferrimagnetic iron-oxide microparticles between 1 and 5 μm diameter
by Möller, Winfried and Scheuch, Gerhard and Sommerer, Knut and Heyder, Joachim
Journal of Magnetism and Magnetic Materials, ISSN 0304-8853, 2001, Volume 225, Issue 1, pp. 8 - 16
The production of spherical monodisperse iron-oxide microparticles in the size range between 0.8 and 5μm is described. The particles can be ferrimagnetic (Fe O... 
Indium-111 (In-111) | Radiolabeling | Alveolar clearance | Monodisperse | Nebulization | Ferrimagnetic | Lung imaging | Spherical | Cell motility | Magnetite | Iron-oxide particles | Spinning top aerosol generator | Preparation | Technetium-99 m (Tc-99 m) | Technetium-99m (Tc-99m)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Full Text A generator for the production of radiolabelled ultrafine carbonaceous particles for deposition and clearance studies in the respiratory tract
by Möller, Winfried and Felten, Kathrin and Seitz, Jürgen and Sommerer, Knut and Takenaka, Shinji and Wiebert, Pernilla and Philipson, Klas and Svartengren, Magnus and Kreyling, Wolfgang G
Journal of Aerosol Science, ISSN 0021-8502, 2006, Volume 37, Issue 5, pp. 631 - 644
A generator for the production of radiolabelled ultrafine carbonaceous particles for inhalation and clearance studies is described. A Technegas generator in... 
Technegas generator | Carbonaceous | Ultrafine particles | Clearance | Technetium-99m | Indium-111 | Inhalation | indium-111 | LUNG | TRANSLOCATION | TECHNEGAS | SIZE | HEALTHY | carbonaceous | ENGINEERING, MECHANICAL | ENGINEERING, CHEMICAL | inhalation | ENVIRONMENTAL SCIENCES | PERTECHNEGAS | AEROSOL | ultrafine particles | technetium-99m | clearance | METEOROLOGY & ATMOSPHERIC SCIENCES | EXPOSURE | VENTILATION AGENT | Leaching
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights